본문 바로가기
KERD
논문KCI 등재후보

2018년 대한부정맥학회 실신 평가 및 치료 지침 – 각론

2018 KHRS guideline for the evaluation and management of syncope

1

조회

0

다운로드

2

인용

0

참고문헌

주제분류의학일반

초록

The general concept and initial approach to syncope patients has been mentioned in the general sections. This special sections have been described the characteristics, diagnosis, and treatment with patient education for the each syncope. It has been described in order of reflex syncope, orthostatic hypotension, postural orthostatic tachycardia syndrome (POTS), cardiac syncope, and unexplained syncope. Several clinical issues will have been dealt with in special issues. Neurological assessment is added when the patients were diagnosed with psychogenic pseudosyncope (PPS). Although many childhood syncope caused by reflex syncope, they are also presented as syncope caused by arrhythmic events in patients with congenital heart disease. In the elderly patients, syncope is because of not only a single cause of syncope but a combination of various conditions. In case of a syncope patient visiting the emergency department, a standardized systematic approach will be required to determine whether hospitalize the patient according to the risk of recurrence and the needs for the syncope management unit. We also mention recommendations on the limits of driving, exercising and social life style that are relevant to syncope in all patients. In this guideline, we reviewed the Korean published literatures and European/American guidelines on syncope. We, writing and publishing committee for evaluation and management guidelines of syncope in the Korean Society for Holter and Noninvasive Electrocardiography (KSHNE) under the Korean Heart Rhythm Society (KHRS) are very pleased to be able to publish this guideline. We also hope this guideline will be a good support to manage the syncope patients and a useful trigger for further research in Korea.

Abstract

The general concept and initial approach to syncope patients has been mentioned in the general sections. This special sections have been described the characteristics, diagnosis, and treatment with patient education for the each syncope. It has been described in order of reflex syncope, orthostatic hypotension, postural orthostatic tachycardia syndrome (POTS), cardiac syncope, and unexplained syncope. Several clinical issues will have been dealt with in special issues. Neurological assessment is added when the patients were diagnosed with psychogenic pseudosyncope (PPS). Although many childhood syncope caused by reflex syncope, they are also presented as syncope caused by arrhythmic events in patients with congenital heart disease. In the elderly patients, syncope is because of not only a single cause of syncope but a combination of various conditions. In case of a syncope patient visiting the emergency department, a standardized systematic approach will be required to determine whether hospitalize the patient according to the risk of recurrence and the needs for the syncope management unit. We also mention recommendations on the limits of driving, exercising and social life style that are relevant to syncope in all patients. In this guideline, we reviewed the Korean published literatures and European/American guidelines on syncope. We, writing and publishing committee for evaluation and management guidelines of syncope in the Korean Society for Holter and Noninvasive Electrocardiography (KSHNE) under the Korean Heart Rhythm Society (KHRS) are very pleased to be able to publish this guideline. We also hope this guideline will be a good support to manage the syncope patients and a useful trigger for further research in Korea.

참고문헌 (248)

  1. Writing Committee M, "2017 ACC", AHA, American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, pp.Heart Rhythm, 2017[DOI]
  2. Brignole M, "2018 ESC Guidelines for the diagnosis and management of syncope", European heart journal (2018)
  3. Wieling W TR, "Symptoms and signs of syncope: a review of the link between physiology and clinical clues", Brain, 132, pp.2630~2642 (2009)
  4. van Dijk JG TR, "The semiology of tilt-induced reflex syncope in relation to electroencephalographic changes", Brain, 137, pp.576~585 (2014)
  5. "J. S. Fits and faints" (1990), Blackwell Scientific Publications
  6. van Dijk JG SR, "Is there any point to vasovagal syncope", Clin Auton Res, 2008, pp.167~169 (2008)
  7. Alboni P AM, "The origin of vasovagal syncope: to protect the heart or to escape predation", Clin Auton Res, 18, pp.170~178 (2008)
  8. Ganzeboom KS CN, "Prevalence and triggers of syncope in medical students", Am J Cardiol, 91, pp.1006~1008 (2003)
  9. Middlekauff HR SW, "Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope", J Am Coll Cardiol, 21, pp.110~116 (1993)
  10. Serletis A RS, "Vasovagal syncope in medical students and their first-degree relatives", European heart journal, 27, pp.1965~1970 (2006)
  11. Colivicchi F AF, "Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score", European heart journal, 24, pp.811~819 (2003)
  12. Del Rosso A, "Clinical predictors of cardiac syncope at initial evaluation in patients referred urgently to a general hospital: the EGSYS score", Heart, 94, pp.1620~1626 (2008)
  13. Brignole M OD, "Longterm outcome in symptomatic carotid sinus hypersensitivity", Am Heart J, 123, pp.687~692 (1992)
  14. Calkins H SY, "The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope", Am J Med, 98, pp.365~373 (1995)
  15. Deharo JC JC, "An implantable loop recorder study of highly symptomatic vasovagal patients: the heart rhythm observed during a spontaneous syncope is identical to the recurrent syncope but not correlated with the head-up tilt test or adenosine triphosphate test", J Am Coll Cardiol, 47, pp.587~593 (2006)
  16. Huff JS DW, "Clinical policy:critical issues in the evaluation and management of adult patients presenting to the emergency department with syncope", Annals of emergency medicine, 49, pp.431~444 (2007)
  17. Jamjoom AA N-EA, "Operating theatre related syncope in medical students: a cross sectional study", BMC Med Educ, 9, pp.14~ (2009)
  18. Sheldon R RS, "Diagnostic criteria for vasovagal syncope based on a quantitative history", European heart journal, 27, pp.344~350 (2006)
  19. Brignole M SR, "International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope", European heart journal, 27, pp.2232~2239 (2006)
  20. Flevari P LD, "Recurrent vasovagal syncope:comparison between clomipramine and nitroglycerin as drug challenges during head-up tilt testing", European heart journal, 30, pp.2249~2253 (2009)
  21. Leitch JW KG, "Syncope associated with supraventricular tachycardia. An expression of tachycardia rate or vasomotor response", Circulation, 85, pp.1064~1071 (1992)
  22. Petersen ME WT, "The normal response to prolonged passive head up tilt testing", Heart, 84, pp.509~514 (2000)
  23. Furukawa T MR, "Effect of clinical triggers on positive responses to tilt-table testing potentiated with nitroglycerin or clomipramine", Am J Cardiol, 107 (2011)
  24. Petix NR DRA, "Nitratepotentiated head-up tilt testing (HUT) has a low diagnostic yield in patients with likely vasovagal syncope", Pacing Clin Electrophysiol, 37, pp.164~172 (2014)
  25. Raviele A MC, "Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope", Am J Cardiol, 76, pp.267~272 (1995)
  26. Sutton R BM, "Twenty-eight years of research permit reinterpretation of tilt-testing: hypotensive susceptibility rather than diagnosis", European heart journal, 35, pp.2211~2212 (2017)
  27. Brignole M GL, "Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation", J Am Coll Cardiol, 22, pp.1123~1129 (1993)
  28. Taneja I MA, "Aortic stenosis and autonomic dysfunction:co-conspirators in syncope", Am J Med Sci, 327, pp.281~283 (2004)
  29. Thomson HL M-TJ, "Reduced cardiopulmonary baroreflex sensitivity in patients with hypertrophic cardiomyopathy", J Am Coll Cardiol, 31, pp.1377~1382 (1998)
  30. Brignole M, "Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome", Am J Cardiol, 68, pp.1032~1036 (1991)
  31. Alboni P, "An abnormal neural reflex plays a role in causing syncope in sinus bradycardia", J Am Coll Cardiol, 22, pp.1130~1134 (1993)
  32. Brignole M AF, "Syncope Unit Project (SUP) Two Investigators. Assessment of a standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncopes", European heart journal, 36, pp.1529~1535 (2015)
  33. Solari D TF, "Stop vasodepressor drugs in reflex syncope: a randomised controlled trial", Heart, 103, pp.449~455 (2017)
  34. SPRINT Research Group WJJ, "A Randomized Trial of Intensive versus Standard Blood- Pressure Control", The New England journal of medicine, 373, pp.2103~2116 (2015)
  35. Brignole M MC, "Effects of longterm vasodilator therapy in patients with carotid sinus hypersensitivity", Am Heart J, 136, pp.264~268 (1998)
  36. Brignole M CF, "Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope", J Am Coll Cardiol, 40, pp.2053~2059 (2002)
  37. Krediet CT vDN, "Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing", Circulation, 106, pp.1684~1689 (2002)
  38. Kim KH CJ, "Usefulness of physical maneuvers for prevention of vasovagal syncope", Circ J, 69, pp.1084~1088 (2005)
  39. van Dijk N QF, "Effectiveness of physical counter pressure maneuvers in preventing vasovagal syncope: the Physical Counter pressure Maneuvers Trial (PC-Trial)", J Am Coll Cardiol, 18, pp.1652~1657 (2006)
  40. Reybrouck T HH, "Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope", Pacing Clin Electrophysiol, 25, pp.1441~1446 (2002)
  41. Zeng H GK, "The effect of orthostatic training in the prevention of vasovagal syncope and its influencing factors", Int Heart J, 49, pp.707~712 (2008)
  42. On YK PJ, "Is home orthostatic self-training effective in preventing neurally mediated syncope?", Pacing Clin Electrophysiol, 30, pp.638~643 (2007)
  43. Burklow TR MJ, "Neurally mediated cardiac syncope: autonomic modulation after normal saline infusion", J Am Coll Cardiol, 33, pp.2059~2066 (1999)
  44. S heldon R RS, "Fludrocortisone for the prevention of vasovagal syncope: a randomized, placebo-controlled trial", J Am Coll Cardiol, 68, pp.1~9 (2016)
  45. Salim MA DST, "Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial", J Am Coll Cardiol, 45, pp.484~488 (2005)
  46. Raviele A BM, "Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebocontrolled trial", The Vasovagal Syncope International Study Circulation, 99, pp.1452~1457 (1999)
  47. Izcovich A GMC, "Midodrine for orthostatic hypotension and recurrent reflex syncope: a systematic review", Neurology, 83, pp.1170~1177 (2014)
  48. Madrid AH OJ, "Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, doubleblind, randomized and placebo-controlled study", J Am Coll Cardiol, 37, pp.554~559 (2001)
  49. Di Girolamo E DIC, "Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study", J Am Coll Cardiol, 33, pp.1227~1230 (1999)
  50. Sheldon R, "Diagnostic criteria for vasovagal syncope based on a quantitative history", European heart journal, 27, pp.344~350 (2006)
  51. Theodorakis GN MM, "Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome", J Am Coll Cardiol, 36, pp.174~178 (2000)
  52. Marquez MF U-MK, "Comparison of metoprolol vs clonazepam as a first treatment choice among patients with neurocardiogenic syncope", Gac Med Mex, 144, pp.503~507 (2008)
  53. Kanjwal K SB, "Use of octreotide in the treatment of refractory orthostatic intolerance", Am J Ther, 19, pp.7~10 (2017)
  54. Freeman R, "Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome", Clin Auton Res, 21, pp.69~72 (2011)
  55. Zia A, "Blood pressure lowering therapy in older people: Does it really cause postural hypotension or falls?", Postgrad Med, 127, pp.186~193 (2015)
  56. McLachlan CY, "Adverse drug events are a major cause of acute medical admission", Intern Med J, 44, pp.633~638 (2014)
  57. Poon IO, "High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans", J Clin Pharm Ther, 30, pp.173~178 (2005)
  58. Huang JJ, "Summer syncope syndrome redux", Am J Med, 128, pp.1140~1143 (2015)
  59. Schroeder C, "Water drinking acutely improves orthostatic tolerance in healthy subjects", Circulation, 106, pp.2806~2811 (2002)
  60. Jordan J, "A potent pressor response elicited by drinking water", Lancet, 353, pp.723~ (1999)
  61. Jordan J, "The pressor response to water drinking in humans : a sympathetic reflex", Circulation, 101, pp.504~509 (2000)
  62. Shannon JR, "Water drinking as a treatment for orthostatic syndromes", Am J Med, 112, pp.355~360 (2002)
  63. Claydon VE, "Salt supplementation improves orthostatic cerebral and peripheral vascular control in patients with syncope", Hypertension, 43, pp.809~813 (2004)
  64. El-Sayed H, "Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope", Heart, 75, pp.134~140 (1996)
  65. Canney M, "Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements:The Irish Longitudinal Study on Ageing", PLoS One, 11, pp.e0146156~ (2016)
  66. Verwoert GC, "Orthostatic hypotension and risk of cardiovascular disease in elderly people:the Rotterdam study", J Am Geriatr Soc, 56, pp.1816~1820 (2008)
  67. Valbusa F, "Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study", J Hypertens, 30, pp.53~60 (2012)
  68. Romero-Ortuno R, "Insights into the clinical management of the syndrome of supine hypertension--orthostatic hypotension (SHOH):the Irish Longitudinal Study on Ageing (TILDA)", BMC Geriatr, 13, pp.73~ (2013)
  69. Fogari R, "Efficacy and safety of two treatment combinations of hypertension in very elderly patients", Arch Gerontol Geriatr, 48, pp.401~405 (2009)
  70. van Lieshout JJ, "Physical manoeuvres for combating orthostatic dizziness in autonomic failure", Lancet, 339, pp.897~898 (1992)
  71. Ten Harkel AD, "Effects of leg muscle pumping and tensing on orthostatic arterial pressure: a study in normal subjects and patients with autonomic failure", Clin Sci (Lond), 87, pp.553~558 (1994)
  72. Tutaj M, "Effect of physical countermaneuvers on orthostatic hypotension in familial dysautonomia", J Neurol, 253, pp.65~72 (2006)
  73. Podoleanu C, "Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study", J Am Coll Cardiol, 48, pp.1425~1432 (2006)
  74. Figueroa JJ, "Effects of patientcontrolled abdominal compression on standing systolic blood pressure in adults with orthostatic hypotension", Arch Phys Med Rehabil, 96, pp.505~510 (2015)
  75. Henry R, "Haemodynamic analysis of efficacy of compression hosiery in elderly fallers with orthostatic hypotension", Lancet, 354, pp.45~46 (1999)
  76. Smit AA, "Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction", Clin Auton Res, 14, pp.167~175 (2004)
  77. Jankovic J, "Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine", Am J Med, 95, pp.38~48 (1993)
  78. Low PA, "Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group", JAMA, 277, pp.1046~1051 (1997)
  79. Wright RA, "A double-blind, doseresponse study of midodrine in neurogenic orthostatic hypotension", Neurology, 51, pp.120~124 (1998)
  80. Rowe PC, "Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome:a randomized controlled trial", JAMA, 285, pp.52~59 (2001)
  81. van Lieshout JJ, "Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure", Clin Auton Res, 10, pp.35~42 (2000)
  82. Coursin DB, "Corticosteroid supplementation for adrenal insufficiency", JAMA, 287, pp.236~240 (2002)
  83. Kaufmann H, "Droxidopa for neurogenic orthostatic hypotension: a randomized, placebocontrolled, phase 3 trial", Neurology, 83, pp.328~335 (2014)
  84. Biaggioni I, "Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa", Hypertension, 65, pp.101~107 (2015)
  85. Hauser RA, "Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A)", J Parkinsons Dis, 4, pp.57~65 (2014)
  86. Mathias CJ, "L-threodihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multinational, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure", Clin Auton Res, 11, pp.235~242 (2001)
  87. Hauser RA, "Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B)", Mov Disord, 30, pp.646~654 (2015)
  88. Omboni S, "Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure", Clin Sci (Lond), 101, pp.609~618 (2001)
  89. Ricci F, "Orthostatic Hypotension:Epidemiology, Prognosis, and Treatment", J Am Coll Cardiol, 66, pp.848~860 (2015)
  90. Ten Harkel AD, "Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone", J Intern Med, 232, pp.139~145 (1992)
  91. Hoeldtke RD, "Effect of the somatostatin analogue SMS-201-995 on the adrenergic response to glucose ingestion in patients with postprandial hypotension", Am J Med, 86, pp.673~677 (1989)
  92. Jarvis SS, "A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductance", J Appl Physiol (1985), 112, pp.1504~1511 (2012)
  93. Raimbach SJ, "Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201-995) in chronic autonomic failure: haemodynamic and hormonal changes", Clin Sci (Lond), 77, pp.623~628 (1989)
  94. Gales BJ, "Pyridostigmine in the treatment of orthostatic intolerance", Ann Pharmacother, 41, pp.314~318 (2007)
  95. Shibao C, "Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure", Hypertension, 56, pp.847~851 (2010)
  96. Benarroch EE, "Postural tachycardia syndrome: a heterogeneous and multifactorial disorder", Mayo Clin Proc, 87, pp.1214~1225 (2012)
  97. Alboni P, "Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: a randomized controlled trial", Circulation, 96, pp.260~266 (1997)
  98. Breivik K, "Sick sinus syndrome treated with permanent pacemaker in 109 patients. A follow-up study", Acta Med Scand, 206, pp.153~159 (1979)
  99. Hartel G, "Treatment of sinoatrial syndrome with permanent cardiac pacing in 90 patients", Acta Med Scand, 198, pp.341~347 (1975)
  100. Rasmussen K, "Chronic sinus node disease: natural course and indications for pacing", European heart journal, 2, pp.455~459 (1981)
  101. Sasaki Y, "Long-term follow-up of patients with sick sinus syndrome: a comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups", Pacing Clin Electrophysiol, 11, pp.1575~1583 (1988)
  102. Sgarbossa EB, "Incidence and predictors of syncope in paced patients with sick sinus syndrome", Pacing Clin Electrophysiol, 15, pp.2055~2060 (1992)
  103. Ng Kam Chuen MJ, "Syncope in paced patients with sick sinus syndrome from the DANPACE trial: incidence, predictors and prognostic implication", Heart, 100, pp.842~847 (2014)
  104. Langenfeld H, "Course of symptoms and spontaneous ECG in pacemaker patients: a 5-year follow-up study", Pacing Clin Electrophysiol, 11, pp.2198~2206 (1988)
  105. Aste M, "Syncope in patients paced for atrioventricular block", Europace, 18, pp.1735~1739 (2016)
  106. Aste M, "Syncope in patients paced for atrioventricular block", Europace, 18, pp.1735~1739 (2016)
  107. Aste M, "Syncope in patients paced for atrioventricular block", Europace, 18, pp.1735~1739 (2016)
  108. Donateo P, "A standardized conventional evaluation of the mechanism of syncope in patients with bundle branch block", Europace, 4, pp.357~360 (2002)
  109. Brignole M, "Mechanism of syncope in patients with bundle branch block and negative electrophysiological test", Circulation, 104, pp.2045~2050 (2001)
  110. Moya A, "Diagnosis, management, and outcomes of patients with syncope and bundle branch block", European heart journal, 32, pp.1535~1541 (2011)
  111. Azocar D, "Syncope and bundle branch block. Diagnostic yield of a stepped use of electrophysiology study and implantable loop recorders", Rev Esp Cardiol, 64, pp.213~219 (2011)
  112. Kalscheur MM, "Long-Term Outcome of Patients with Bifascicular Block and Unexplained Syncope Following Cardiac Pacing", Pacing Clin Electrophysiol, 39, pp.1126~1131 (2016)
  113. Santini M, "Prevention of syncope through permanent cardiac pacing in patients with bifascicular block and syncope of unexplained origin: the PRESS study", Circ Arrhythm Electrophysiol, 6, pp.101~107 (2013)
  114. Englund A, "Diagnostic value of programmed ventricular stimulation in patients with bifascicular block: a prospective study of patients with and without syncope", J Am Coll Cardiol, 26, pp.1508~1515 (1995)
  115. Morady F, "Electrophysiologic testing in bundle branch block and unexplained syncope", Am J Cardiol, 54, pp.587~591 (1984)
  116. Tabrizi F, "Long-term prognosis in patients with bifascicular block--the predictive value of noninvasive and invasive assessment", J Intern Med, 260, pp.31~38 (2006)
  117. Olshansky B, "Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study", J Am Coll Cardiol, 51, pp.1277~1282 (2008)
  118. Ruwald MH, "Syncope in high-risk cardiomyopathy patients with implantable defibrillators:frequency, risk factors, mechanisms, and association with mortality: results from the multicenter automatic defibrillator implantation trial-reduce inappropriate therapy (MADIT-RIT)study", Circulation, 129, pp.545~552 (2014)
  119. Shen WK, "2017 ACC", AHA, American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, pp.Circulation, 2017[DOI]
  120. Task Force for the D, "Guidelines for the diagnosis and management of syncope (version 2009)", European heart journal, 30, pp.2631~2671 (2009)
  121. Brignole M, "2018 ESC Guidelines for the diagnosis and management of syncope", European heart journal, 39, pp.1883~1948 (2018)
  122. Chapelon-Abric C, "Cardiac sarcoidosis: a retrospective study of 41 cases", Medicine, 83, pp.315~334 (2004)
  123. Priori SG, "2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by:Association for European Paediatric and Congenital Cardiology (AEPC)", European heart journal, 36, pp.2793~2867 (2015)
  124. Kusumoto FM, "HRS", ACC, Circulation, pp.2014, 130[DOI]
  125. Epstein AE, "2012 ACCF", AHA, AHA, pp.HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[DOI]
  126. Spirito P, "Syncope and risk of sudden death in hypertrophic cardiomyopathy", Circulation, 119, pp.1703~1710 (2009)
  127. Task Force m, "2014ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)", European heart journal, 35, pp.2733~2779 (2014)
  128. Schinkel AF, "Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia", cardiomyopathy:patient outcomes, incidence of appropriate and inappropriate interventions, and complications, 2013, pp.6, 562~568
  129. Corrado D, "Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy", dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia, 2010, pp.122, 1144~1152
  130. Corrado D, "Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy", Dysplasia:An International Task Force Consensus Statement, 2015, pp.132, 441~453
  131. Link MS, "Ventricular arrhythmias in the North American multidisciplinary study of ARVC:predictors, characteristics, and treatment", J Am Coll Cardiol, 64, pp.119~125 (2014)
  132. Goldenberg I, "Long QT syndrome", J Am Coll Cardiol, 51, pp.2291~2300 (2008)
  133. Fauchier L, "Prognostic value of programmed ventricular stimulation in Brugada syndrome according to clinical presentation: an updated meta-analysis of worldwide published data", International journal of cardiology, 168, pp.3027~3029 (2013)
  134. Brignole M, "2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)", European heart journal, 34, pp.2281~2329 (2013)
  135. Zhao W, "Safety and Efficacy of Remote Ischemic Preconditioning in Patients With Severe Carotid Artery Stenosis Before Carotid Artery Stenting: A Proof-of-Concept, Randomized Controlled Trial", Circulation, 135, pp.1325~1335 (2017)
  136. van der Lende M, "Cardiac arrhythmias during or after epileptic seizures", J Neurol Neurosurg Psychiatry, 87, pp.69~74 (2016)
  137. Rugg-Gunn FJ, "Cardiac arrhythmias in focal epilepsy: a prospective long-term study", Lancet, 364, pp.2212~2219 (2004)
  138. Benditt DG, "Ictal asystole: life-threatening vagal storm or a benign seizure self-termination mechanism", Circ Arrhythm Electrophysiol, 8, pp.11~14 (2015)
  139. 강도윤, "Recurrent Syncope Triggered by Temporal Lobe Epilepsy: Ictal Bradycardia Syndrome", Korean Circulation Journal, 42(5), pp.349~351 (2012), 대한심장학회
  140. Rocamora R, "Cardiac asystole in epilepsy: clinical and neurophysiologic features", Epilepsia, 44, pp.179~185 (2003)
  141. Schuele SU, "Videoelectrographic and clinical features in patients with ictal asystole", Neurology, 69, pp.434~441 (2007)
  142. Bestawros M, "Ictal asystole and ictal syncope: insights into clinical management", Circ Arrhythm Electrophysiol, 8, pp.159~164 (2015)
  143. Lamberts RJ, "Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk", Epilepsia, 53, pp.253~257 (2012)
  144. Lamberts RJ, "Sudden cardiac arrest in people with epilepsy in the community: Circumstances and risk factors", Neurology, 85, pp.212~218 (2015)
  145. Horrocks IA, "Anoxicepileptic seizures: observational study of epileptic seizures induced by syncopes", Arch Dis Child, 90, pp.1283~1287 (2005)
  146. Stephenson J, "Anoxic-epileptic seizures: home video recordings of epileptic seizures induced by syncopes", Epileptic Disord, 6, pp.15~19 (2004)
  147. 송필상, "Seizure-Like Activities during Head-Up Tilt Test- Induced Syncope", Yonsei Medical Journal, 51(1), pp.77~81 (2010), 연세대학교의과대학
  148. van Dijk JG, "The semiology of tiltinduced reflex syncope in relation to electroencephalographic changes", Brain, 137, pp.576~585 (2014)
  149. Tannemaat MR, "The semiology of tilt-induced psychogenic pseudosyncope", Neurology, 81, pp.752~758 (2013)
  150. Hoefnagels WA, "Transient loss of consciousness: the value of the history for distinguishing seizure from syncope", J Neurol, 238, pp.39~43 (1991)
  151. Abubakr A, "Seizures in the elderly: Video", EEG monitoring analysis, 2005, pp.7, 447~450
  152. 강구현, "Diagnostic Patterns in the Evaluation of Patients Presenting with Syncope at the Emergency or Outpatient Department", Yonsei Medical Journal, 53(3), pp.517~523 (2012), 연세대학교의과대학[DOI]
  153. Pires LA, "Diagnostic patterns and temporal trends in the evaluation of adult patients hospitalized with syncope", Arch Intern Med, 161, pp.1889~1895 (2001)
  154. Sclafani JJ, "Intensive education on evidence-based evaluation of syncope increases sudden death risk stratification but fails to reduce use of neuroimaging", Arch Intern Med, 170, pp.1150~1154 (2010)
  155. Mendu ML, "Yield of diagnostic tests in evaluating syncopal episodes in older patients", Arch Intern Med, 169, pp.1299~1305 (2009)
  156. Johnson PC, "Yield of diagnostic tests and its impact on cost in adult patients with syncope presenting to a community hospital", South Med J, 107, pp.707~714 (2014)
  157. Hoefnagels WA, "Syncope or seizure? A matter of opinion", Clin Neurol Neurosurg, 94, pp.153~156 (1992)
  158. Benbadis SR, "Value of tongue biting in the diagnosis of seizures", Arch Intern Med, 155, pp.2346~2349 (1995)
  159. Tannemaat MR, "Managing psychogenic pseudosyncope: Facts and experiences", Cardiol J, 21, pp.658~664 (2014)
  160. Raj V, "Psychogenic pseudosyncope: diagnosis and management", Auton Neurosci, 184, pp.66~72 (2014)
  161. "The European Society of Cardiology Guidelines for the diagnosis and management of syncope reviewed by Angel Moya, MD, FESC, Chair of the Guideline Taskforce with J. Taylor, MPhil", European heart journal, 30, pp.2539~2540 (2009)
  162. Benbadis SR, "Psychogenic pseudosyncope: an underestimated and provable diagnosis", Epilepsy Behav, 9, pp.106~110 (2006)
  163. LaFrance WC Jr, "Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force", Epilepsia, 54, pp.2005~2018 (2013)
  164. LaFrance WC, Jr., "Management of psychogenic nonepileptic seizures", Epilepsia, 54(Suppl 1), pp.53~67 (2013)
  165. Saal DP, "Long-term follow-up of psychogenic pseudosyncope", Neurology, 87, pp.2214~2219 (2016)
  166. LaFrance WC, Jr., "Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures", Neurology, 75, pp.1166~1173 (2010)
  167. LaFrance WC, Jr, "Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial", JAMA Psychiatry, 71, pp.997~1005 (2014)
  168. Kanjwal K, "Syncope in Children and Adolescents", Cardiol Clin, 33, pp.397~409 (2015)
  169. Massin MM, "Syncope in pediatric patients presenting to an emergency department", J Pediatr-Us, 145, pp.223~228 (2004)
  170. DiMario FJ, Jr., "Prospective study of children with cyanotic and pallid breath-holding spells", Pediatrics, 107, pp.265~269 (2001)
  171. Kelly AM, "Breath-holding spells associated with significant bradycardia: successful treatment with permanent pacemaker implantation", Pediatrics, 108, pp.698~702 (2001)
  172. Writing Committee M, "2017ACC", AHA, American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, pp.Heart Rhythm, 2017[DOI]
  173. Tretter JT, "Distinguishing cardiac syncope from vasovagal syncope in a referral population", J Pediatr-Us, 163, pp.1618~1623e1 (2013)
  174. Zhang Q, "The diagnostic protocol in children and adolescents with syncope: a multi-centre prospective study", Acta Paediatr, 98, pp.879~884 (2009)
  175. Avari Silva JN, "Implantable Loop Recorder Monitoring for Refining Management of Children With Inherited Arrhythmia Syndromes", J Am Heart Assoc, 5 (2016)
  176. Joseph Rossano BB, "Efficacy of Implantable Loop Recorders in Establishing Symptom-Rhythm Correlation in Young Patients With Syncope and Palpitations", Pediatrics, 112, pp.e228~e233 (2003)
  177. Al Dhahri KN, "Are implantable loop recorders useful in detecting arrhythmias in children with unexplained syncope?", Pacing Clin Electrophysiol, 32, pp.1422~1427 (2009)
  178. Strieper MJ, "Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope", J Am Coll Cardiol, 22, pp.594~597 (1993)
  179. McLeod KA, "Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures", Heart, 82, pp.721~725 (1999)
  180. Zhang Q, "Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents", Med Sci Monitor, 14, pp.CR199~CR203 (2008)
  181. Maron MS, "Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction", Circulation, 114, pp.2232~2239 (2006)
  182. Shen WK, "2017 ACC", AHA, American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, pp.J Am Coll Cardiol, 2017[DOI]
  183. Khairy P, "Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multiinstitutional study", Circulation, 122, pp.868~875 (2010)
  184. Khairy P, "Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study", Circ Arrhythm Electrophysiol, 1, pp.250~257 (2008)
  185. Berul CI, "Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients", J Am Coll Cardiol, 51, pp.1685~1691 (2008)
  186. Khairy P, "Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study", Circulation, 109, pp.1994~2000 (2004)
  187. Ungar A, "Diagnosis and characteristics of syncope in older patients referred to geriatric departments", J Am Geriatr Soc, 54, pp.1531~1536 (2006)
  188. Goyal P, "Syncope in older adults", Journal of geriatric cardiology : JGC, 13, pp.380~386 (2016)
  189. Ruwald MH, "Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85versus >", =85 years of age, 2013, pp.112, 1610~1615
  190. Romme JJ, "Influence of age and gender on the occurrence and presentation of reflex syncope", Clin Auton Res, 18, pp.127~133 (2008)
  191. Bhangu JS, "The relationship between syncope, depression and anti-depressant use in older adults", Age and ageing, 43, pp.502~509 (2014)
  192. Jansen S, "Self-reported cardiovascular conditions are associated with falls and syncope in community-dwelling older adults", Age and ageing, 44, pp.525~529 (2015)
  193. Mossello E, "Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs", JAMA internal medicine, 175, pp.578~585 (2015)
  194. Ryan DJ, "Syncope causes transient focal neurological symptoms", QJM : monthly journal of the Association of Physicians, 108, pp.711~718 (2015)
  195. Parry SW, "Drop attacks in older adults: systematic assessment has a high diagnostic yield", J Am Geriatr Soc, 53, pp.74~78 (2005)
  196. Davies AJ, "Falls presenting to the accident and emergency department: types of presentation and risk factor profile", Age and ageing, 25, pp.362~366 (1996)
  197. Jansen S, "The Association of Cardiovascular Disorders and Falls:A Systematic Review", Journal of the American Medical Directors Association, 17, pp.193~199 (2016)
  198. Rafanelli M, "Clinical aspects and diagnostic relevance of neuroautonomic evaluation in patients with unexplained falls", Aging clinical and experimental research, 26, pp.33~37 (2014)
  199. Kenny RA, "Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE)", J Am Coll Cardiol, 38, pp.1491~1496 (2001)
  200. O'Dwyer C, "Amnesia for loss of consciousness is common in vasovagal syncope", Europace, 13, pp.1040~1045 (2011)
  201. Shaw FE, "Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomised controlled trial", BMJ (Clinical research ed), 326, pp.73~ (2003)
  202. Frewen J, "Orthostatic hypotension is associated with lower cognitive performance in adults aged 50 plus with supine hypertension", The journals of gerontology Series A, Biological sciences and medical sciences, 69, pp.878~885 (2014)
  203. Robertson DA, "Cognitive function in the prefrailty and frailty syndrome", J Am Geriatr Soc, 62, pp.2118~2124 (2014)
  204. Robertson DA, "Frailty and cognitive impairment--a review of the evidence and causal mechanisms", Ageing research reviews, 12, pp.840~851 (2013)
  205. Racco F, "Longterm follow-up after syncope. A group of 183 patients observed for 5 years", Minerva cardioangiologica, 48, pp.69~78 (2000)
  206. Matthews IG, "Syncope in the Older Person", Cardiol Clin, 33, pp.411~421 (2015)
  207. de Ruiter SC, "Multiple causes of syncope in the elderly: diagnostic outcomes of a Dutch multidisciplinary syncope pathway", Europace, 20, pp.867~872 (2018)
  208. Colivicchi F, "Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome", European heart journal, 23, pp.1125~1130 (2002)
  209. Sneddon JF, "Exercise induced vasodepressor syncope", British heart journal, 71, pp.554~557 (1994)
  210. Sakaguchi S, "Syncope associated with exercise, a manifestation of neurally mediated syncope", Am J Cardiol, 75, pp.476~481 (1995)
  211. Pappas LK, "Exercise-induced second-degree atrioventricular block", International journal of cardiology, 111, pp.461~463 (2006)
  212. Ho WJ, "Exercise-induced myocardial ischaemia complicated by paroxysmal complete atrioventricular block", International journal of clinical practice Supplement, pp.19~22 (2005)
  213. Woelfel AK, "Exerciseinduced distal atrioventricular block", J Am Coll Cardiol, 2, pp.578~581 (1983)
  214. Shah JS, "Prevalence of exerciseinduced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy", Heart, 94, pp.1288~1294 (2008)
  215. Colivicchi F, "Epidemiology and prognostic implications of syncope in young competing athletes", European heart journal, 25, pp.1749~1753 (2004)
  216. Hastings JL, "Syncope in the athletic patient", Progress in cardiovascular diseases, 54, pp.438~444 (2012)
  217. Vettor G, "Syncope as a Warning Symptom of Sudden Cardiac Death in Athletes", Cardiol Clin, 33, pp.423~432 (2015)
  218. Asplund CA, "Exercise-associated collapse: an evidence-based review and primer for clinicians", British journal of sports medicine, 45, pp.1157~1162 (2011)
  219. Pelliccia A, "Bethesda Conference #36 and the European Society of Cardiolog y Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities", J Am Coll Cardiol, 52, pp.1990~1996 (2008)
  220. Zipes DP, "Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology", Circulation, 132, pp.e315~e325 (2015)
  221. O'Connor FG, "Practical management: a systematic approach to the evaluation of exercise-related syncope in athletes", Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine, 19, pp.429~434 (2009)
  222. Albert RK, "Macrolide antibiotics and the risk of cardiac arrhythmias", American journal of respiratory and critical care medicine, 189, pp.1173~1180 (2014)
  223. Simpson C, "Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary", The Canadian journal of cardiology, 20, pp.1314~1320 (2004)
  224. an VH, "Prospective Assessment of the Risk of Vasovagal Syncope During Driving", JACC Clin Electrophysiol, 2, pp.203~208 (2016)
  225. Sorajja D, "Driving guidelines and restrictions in patients with a history of cardiac arrhythmias, syncope,or implantable devices", Current treatment options in cardiovascular medicine, 12, pp.443~456 (2010)
  226. Lamb LE, "Incidence of loss of consciousness in 1,980 Air Force personnel", Aerospace medicine, 31, pp.973~988 (1960)
  227. Morichetti A, "Epidemiological and clinical findings in 697 syncope events", Minerva medica, 89, pp.211~220 (1998)
  228. Soteriades ES, "Incidence and prognosis of syncope", The New England journal of medicine, 347, pp.878~885 (2002)
  229. Blanc JJ, "Prospective evaluation and outcome of patients admitted for syncope over a 1 year period", European heart journal, 23, pp.815~820 (2002)
  230. Costantino G, "Short- and long-term prognosis of syncope, risk factors, and role of hospital admission:results from the STePS (Short-Term Prognosis of Syncope) study", J Am Coll Cardiol, 51, pp.276~283 (2008)
  231. Shen WK, "Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope management", Circulation, 110, pp.3636~3645 (2004)
  232. Brignole M, "Syncope management from emergency department to hospital", J Am Coll Cardiol, 51, pp.284~287 (2008)
  233. 윤희, "실신을 주소로 응급실에 내원한 환자의 진단적 검사 유형과 의료 비용에 대한 연구", 대한응급의학회지, 22(6), pp.662~668 (2011), 대한응급의학회
  234. Grossman AM, "Comparison of 1-Day Emergency Department Observation and Inpatient Ward for 1-Day Admissions in Syncope Patients", The Journal of emergency medicine, 50, pp.217~222 (2016)
  235. Lin M, "Observation vs admission in syncope: can we predict short length of stays", The American journal of emergency medicine, 33, pp.1684~1686 (2015)
  236. Filippo Numeroso, "Role of emergency department observation units in the management of patients with unexplained syncope: a critical review and meta-analysis", Clinical and Experimental Emergency Medicine, 4(4), pp.201~207 (2017), 대한응급의학회[DOI]
  237. Probst MA, "How can we improve management of syncope in the Emergency Department", Cardiol J, 21, pp.643~650 (2014)
  238. 신태건, "Standardized Approaches to Syncope Evaluation for Reducing Hospital Admissions and Costs in Overcrowded Emergency Departments", Yonsei Medical Journal, 54(5), pp.1110~1118 (2013), 연세대학교의과대학[DOI]
  239. Sun BC, "Randomized clinical trial of an emergency department observation syncope protocol versus routine inpatient admission", Annals of emergency medicine, 64, pp.167~175 (2014)
  240. Sheldon R, "Historical criteria that distinguish syncope from seizures", J Am Coll Cardiol, 40, pp.142~148 (2002)
  241. Crane SD, "Risk stratification of patients with syncope in an accident and emergency department", Emergency medicine journal : EMJ, 19, pp.23~27 (2002)
  242. Numeroso F, "Short-term Prognosis and Current Management of Syncopal Patients at Intermediate Risk: Results from the IRiS (Intermediate-Risk Syncope) Study", Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 23, pp.941~948 (2016)
  243. Maisel WH, "Specialized syncope evaluation", Circulation, 110, pp.3621~3623 (2004)
  244. Q uinn J, "Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes", Annals of emergency medicine, 47, pp.448~454 (2006)
  245. Ricci F, "Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies", European heart journal, 36, pp.1609~1617 (2015)
  246. Perego F, "Predictors of hospital admission after syncope: relationships with clinical risk scores", International journal of cardiology, 161, pp.182~183 (2012)
  247. Canzoniero JV, "Unnecessary hospitalization and related harm for patients with low-risk syncope", JAMA internal medicine, 175, pp.1065~1067 (2015)
  248. Ungar A, "Assessment of a structured management pathway for patients referred to the Emergency Department for syncope: results in a tertiary hospital", Europace, 18, pp.457~462 (2016)

관련 논문AI추천

이 간행물의 다른 논문 (4건)